Optiscan Imaging Limited has released a press release.
Halfway Mark Reached in Optiscan Breast Cancer Study
Earlier from Optiscan Imaging
- Second Anniversary of Optiscan and Mayo Clinic Agreement
- Optiscan Receives $1.69m R&D Tax Refund
- Optiscan Submits InSpecta FDA Dossier